Pediatric Oncology Pharmacist Stays On the Job With Colorectal Cancer

As a pediatric pharmacist located in Dana-Farber’s Jimmy Fund Clinic, Patrick never tires of seeing smiling, young cancer patients enjoying the clinic’s playroom. The resilience they display throughout infusions, blood draws, and other procedures not only inspires him, but it also serves as a source of resolve he carries into his ongoing cancer care. Patrick, … Read more

Team Beyond Colorectal Cancer Members Ensure Another Excellent Jimmy Fund Walk

The team representing Dana-Farber’s Young-Onset Colorectal Cancer Center called Team Beyond CRC (colorectal cancer) is looking forward to the fast-approaching Boston Marathon® Jimmy Fund Walk presented by Hyundai taking place on Sunday, October 2. Team Beyond CRC will be among 90 other employee-led teams participating in the Jimmy Fund Walk. This longtime annual event brings … Read more

Trouble Swallowing: What You Need to Know

Difficulty swallowing, known as dysphagia, can come in many forms. Some people with dysphagia may experience issues in the oral phase or mouth. This is characterized by one or more of the following: holding food in the cheek without being aware of it due to weakness difficulty moving the food around the mouth leakage of … Read more

Young Colorectal Cancer Patient Works with Care Team to Reduce Risk of Recurrence

At 43, Erick Eigner was leading a healthy and fulfilling life: spending time with family, working in marketing at Microsoft, and hitting the gym six days a week. Cancer was the last thing he was thinking about when he went to the doctor for a physical and mentioned some concerns he had about swallowing. The … Read more

Junior Dana-Farber Analyst Named to Forbes Healthcare’s 30 under 30

At 28 years old, Dana-Farber bioinformatics analyst Carino Gurjao is already making a splash in the field of colorectal cancer research. He is coming off the back of a big year: The Paris-born researcher was named to Forbes Healthcare’s 2022 30 Under 30 list for his role in the Giannakis Lab at Dana-Farber, which identified … Read more

Providing Emotional Support to Young Patients with Colorectal Cancer

Cancer is a disease that’s often associated with older people; however, a growing number of younger patients are being diagnosed with colorectal cancer. Since the 1990s, the rate of colorectal cancer diagnoses has more than doubled in adults age 20 to 49. Alexa Morell is one of these patients. She didn’t expect her diagnosis: metastatic … Read more

Stomach Cancer in the African American Community: Information to Know

Although stomach cancer is a rare disease, African Americans have a higher risk of developing it than white Americans do. Incidence rates of stomach cancer are 1.8 times higher in non-Hispanic Black men and 2.2 times higher in non-Hispanic Black women than in white men and women, respectively, according to the American Cancer Society. (These … Read more

After Colon Cancer With More Than 175 Genetic Mutations, Patient is in Remission

When Michael Voisine went to the doctor in 2017, he had just one symptom: a burning sensation on his skin, right around the corner of his stomach. After a CAT scan, he was rushed into the operating room for an emergency appendectomy. But doctors found more than just an inflamed appendix: They also discovered an … Read more

Immunotherapy is Lifesaver for Firefighter with Rare Bile Duct Cancer

As a former volunteer firefighter, Paul Calnan prided himself on being ready for any emergency. He thought nothing could rattle him — until, at age 47, doctors discovered a large, malignant tumor in his liver. The diagnosis was stage IV intrahepatic cholangiocarcinoma, a rare form of bile duct cancer that had presented in Calnan’s liver. … Read more

New ‘Druggable’ Genetic Targets Identified in Rare Type of Bile Duct Cancer

Scientists are beginning to make inroads into treating cholangiocarcinoma, a rare, lethal cancer of the bile ducts, with precision drugs. Last year, the first targeted drug for some patients with the disease was approved. Now, Dana-Farber scientists say they have identified another genetic alteration in a small percentage of cholangiocarcinoma patients that can be attacked … Read more

Dramatic Turns, Epiphanies Mark Patient’s Journey with Colorectal Cancer

Khiem Tran’s response to drug therapy for advanced colorectal cancer seemed to defy the severity of his disease. After just a few doses of chemotherapy and a targeted drug, the cancer, which had spread from his rectum to his liver, was in full retreat, with a key marker of tumor burden dropping from stratospheric levels … Read more

Colorectal Cancer in the Black Community: Information to Know

Communities of color, particularly Black Americans, have long faced health disparities and a disproportionate burden of cancer. Colorectal cancer is no exception. Colorectal cancer occurs at a higher rate in Black Americans than any other racial or ethnic group in the U.S., according to the American Cancer Society. African Americans are more than 20% more … Read more

Dana-Farber Opens New Doors for Patient Battling Metastatic Colon Cancer

Paul Rawate has never been one to sit still. Whether it was getting his blackbelt in Taekwondo at just 8 years old or growing up to run a successful business, the 45-year-old has always kept his eye on the next challenge. In 2018, Rawate faced an entirely new obstacle when he was diagnosed with metastatic … Read more

Appendix Cancer: What You Should Know

Appendix cancer, or appendiceal cancer, is an incredibly rare cancer, occurring in roughly one person out of every 100,000. Despite its rarity, appendiceal tumors come in a variety of forms and presents very differently from person to person. There are treatment options for appendiceal cancer, and it usually comes with a relatively good prognosis. Here, … Read more